Literature DB >> 30814075

Dexmedetomidine Attenuates Renal and Myocardial Ischemia/Reperfusion Injury in a Dose-Dependent Manner by Inhibiting Inflammatory Response.

Zhihua Xu1,2, Dong Wang3,2, Zhumei Zhou1, Qiu Chen4, Dan Zhang1, Shuo Chen1, Han Jiang1, Chao Jia1, Xusen Liu1.   

Abstract

OBJECTIVE: To investigate the effect of dexmedetomidine (DEX) against renal and myocardial ischemia/reperfusion (I/R) injury induced by renal I/R and explore its potential mechanism.
METHODS: Male Wistar rats were randomly allocated to sham, I/R, D1, D2 and D3 group. The sham group received laparotomy without a renal ischemia. I/R injury model was induced by bilateral renal pedicle clamping for 120 min followed by 3 h of reperfusion in I/R, D1, D2 and D3 group. Then D1, D2 and D3 group received DEX of 25 μg/kg, 50 μg/kg and 100 μg/kg by intraperitoneal injection at 30 min from ischemia onset, respectively, and I/R group received normal saline. Renal histopathology, myocardial histopathology and inflammatory cytokines were assessed.
RESULTS: Renal and myocardial tissues were normal in the sham group. Pathological damage showed a trend of I/R>D1>D2>D3 group in renal and myocardial tissue, and the damage was negatively correlated with the dose of DEX. The concentration of creatinine and blood urea nitrogen in serum showed a trend of I/R>D1>D2>D3>sham group. The concentration of tumor necrosis factor α in renal and myocardial tissue showed a trend of I/R>D1>D2>D3>sham group. The concentration of interleukin-10 in renal and myocardial tissue showed a trend of D3>D2>D1>I/R>sham group.
CONCLUSION: DEX could attenuate renal and myocardial I/R injury induced by renal I/R in a dose-dependent manner, at least in part, through its inhibitory effects on inflammatory response.
© 2019 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  Dexmedetomidine; Histopathology; Inflammatory response; Ischemia/reperfusion

Mesh:

Substances:

Year:  2019        PMID: 30814075

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  5 in total

1.  Effects of Dexmedetomidine Administered Through Different Routes on Kidney Tissue in Rats with Spinal Cord Ischaemia-Reperfusion Injury.

Authors:  Necmiye Şengel; Zeynep Köksal; Ali Doğan Dursun; Ömer Kurtipek; Şaban Cem Sezen; Mustafa Arslan; Mustafa Kavutçu
Journal:  Drug Des Devel Ther       Date:  2022-07-13       Impact factor: 4.319

2.  Up-regulating microRNA-138-5p enhances the protective role of dexmedetomidine on myocardial ischemia-reperfusion injury mice via down-regulating Ltb4r1.

Authors:  Yanzi Chang; Lika Xing; Wenjuan Zhou; Wei Zhang
Journal:  Cell Cycle       Date:  2021-01-28       Impact factor: 4.534

3.  Protective effects of dexmedetomidine on hypoxia/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway.

Authors:  Xiaoqiao Shi; Zhiwen Liu; Junwei Li
Journal:  Mol Med Rep       Date:  2020-08-19       Impact factor: 2.952

4.  Effects of different sedatives/analgesics on stress responses in patients undergoing craniotomy and bone flap decompression.

Authors:  Qingduo Guo; Meina Ma; Qiuying Yang; Hong Yu; Xupeng Wang; Chunling Wu; Rui Li
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

5.  DL-3-n-butylphthalide protects H9c2 cardiomyoblasts from ischemia/reperfusion injury by regulating HSP70 expression via PI3K/AKT pathway activation.

Authors:  Yunchen Yu; Yuying Zhu; Xiaotong Sun; Yongxing Li; Mingling Wang; Bin Dong; Xiaodong Sun; Wenming Hou
Journal:  Exp Ther Med       Date:  2021-07-15       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.